Medifast Inc.
MED | NYSE
$12.26
+$0.49 (+4.16%)
At close: Sep 21, 2026, 4:00 PM ET
$12.26
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Market Data
Market Cap $130.87M
Enterprise Value $-5.88M
Beta 0.73
Average Volume 206.29K
Shares Outstanding (Diluted) 11.14M
Shares Change YoY 0.68%
Institutional Ownership 78.16%
Exchange NYSE
ISIN US58470H1014
Price Performance
Price Change 1M 2.2%
Price Change 3M 15.4%
Price Change 6M 27.8%
Price Change YTD 17.9%
Price Change 1Y -14.4%
Price Change 3Y -84.2%
Price Change 5Y -94.0%
1M CAGR (ann.) -2.9%
1Y CAGR (ann.) -16.7%
5Y CAGR (ann.) -43.7%
All-Time CAGR 2.9%
Valuation
PE Ratio -5.26
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.07
PS Ratio 0.43
Forward PS 0.50
PB Ratio 0.69
P/FCF Ratio 33.97
P/Adj. FCF Ratio -48.98
P/OCF Ratio 15.52
EV/Sales -0.02
EV/EBIT 0.42
EV/EBITDA 1.65
EV/FCF -1.47
Earnings Yield -19.0%
FCF Yield 2.9%
Adj. FCF Yield -2.0%
Financial Health
Net Cash $169.82M
Total Debt $27.62M
Cash & Short-Term Investments $169.82M
Total Assets $260.4M
Current Ratio 4.86
Quick Ratio 4.35
Debt / Equity Ratio 0.14
Debt / EBITDA -7.73
Debt / FCF 6.88
OCF / Debt 0.32
Interest Coverage 0.00
Altman Z-Score 3.83
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 69.2%
Operating Profit Margin -5.5%
EBITDA Margin -1.1%
Net Profit Margin -8.1%
FCF Margin 1.3%
Adj. FCF Margin -0.9%
SBC / Revenue 2.1%
SBC Impact (per share) -169.3%
Returns
Return on Assets -9.8%
Return on Equity -12.7%
Return on Invested Capital -7.7%
Return on Capital Employed -7.9%
Return on Tangible Assets -9.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -38.6%
Revenue CAGR 5Y -24.3%
Revenue CAGR 10Y 1.6%
EPS CAGR 3Y -1200.0%
EPS CAGR 5Y -82.8%
EPS CAGR 10Y -6.3%
FCF CAGR 3Y -72.8%
FCF CAGR 5Y -50.1%
FCF CAGR 10Y -17.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 12
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $59.67
Price Target Upside 386.7%
Cash Flow
Operating Cash Flow $8.79M
Free Cash Flow $4.01M
Adj. Free Cash Flow $-2.78M
FCF Per Share $0.36
OCF Per Share $0.79
OCF/S Ratio 2.8%
Income Statement
Revenue $316.93M
Gross Profit $219.45M
Operating Income $-17.31M
EBITDA $-3.57M
Net Income $-25.6M
EPS (Diluted) -$2.33
Revenue / Employee $834.03K
Profit / Employee $-67.37K
Employees 380
Add to Watchlist
Select watchlists to add or remove MED